These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24697169)

  • 1. Targeting liver cancer via ASGP receptor using 5-FU-loaded surface-modified PLGA nanoparticles.
    Dangi R; Hurkat P; Jain A; Shilpi S; Jain A; Gulbake A; Jain SK
    J Microencapsul; 2014; 31(5):479-87. PubMed ID: 24697169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles.
    Wang Y; Li P; Chen L; Gao W; Zeng F; Kong LX
    Drug Deliv; 2015 Feb; 22(2):191-8. PubMed ID: 24437926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
    Srivastava S; Gupta S; Mohammad S; Ahmad I
    J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan.
    Emami J; Maghzi P; Hasanzadeh F; Sadeghi H; Mirian M; Rostami M
    Pharm Dev Technol; 2018 Jan; 23(1):41-54. PubMed ID: 28608760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy.
    Gong X; Zheng Y; He G; Chen K; Zeng X; Chen Z
    Drug Deliv; 2019 Dec; 26(1):595-603. PubMed ID: 31195837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer.
    Guan X; Gao M; Xu H; Zhang C; Liu H; Lv L; Deng S; Gao D; Tian Y
    Drug Deliv; 2016 Nov; 23(9):3307-3318. PubMed ID: 27067032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondroitin sulphate decorated nanoparticulate carriers of 5-fluorouracil: development and in vitro characterization.
    Yadav AK; Agarwal A; Jain S; Mishra AK; Bid H; Rai G; Agrawal H; Agrawal GP
    J Biomed Nanotechnol; 2010 Aug; 6(4):340-50. PubMed ID: 21323107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
    Li X; Xu Y; Chen G; Wei P; Ping Q
    Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.
    Bao X; Gao M; Xu H; Liu KX; Zhang CH; Jiang N; Chu QC; Guan X; Tian Y
    Drug Dev Ind Pharm; 2015; 41(7):1193-203. PubMed ID: 25026246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: in vitro and in vivo studies.
    Kumar V; Bhatt PC; Rahman M; Kaithwas G; Choudhry H; Al-Abbasi FA; Anwar F; Verma A
    Int J Nanomedicine; 2017; 12():6747-6758. PubMed ID: 28932118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
    Nasr M; Nafee N; Saad H; Kazem A
    Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the cytotoxic effects of PLGA coated iron oxide nanoparticles as a carrier of 5- fluorouracil and mega-voltage X-ray radiation in DU145 prostate cancer cell line.
    Hajikarimi Z; Khoei S; Khoee S; Mahdavi SR
    IEEE Trans Nanobioscience; 2014 Dec; 13(4):403-8. PubMed ID: 25051558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of sulfadiazine-decorated PLGA nanoparticles loaded with 5-fluorouracil and cell viability.
    Guimarães PP; Oliveira SR; de Castro Rodrigues G; Gontijo SM; Lula IS; Cortés ME; Denadai ÂM; Sinisterra RD
    Molecules; 2015 Jan; 20(1):879-99. PubMed ID: 25580685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer.
    Badran MM; Mady MM; Ghannam MM; Shakeel F
    Int J Biol Macromol; 2017 Feb; 95():643-649. PubMed ID: 27908720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer.
    Bhattacharya S
    Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long circulating PEGylated PLGA nanoparticles of cytarabine for targeting leukemia.
    Yadav KS; Jacob S; Sachdeva G; Chuttani K; Mishra AK; Sawant KK
    J Microencapsul; 2011; 28(8):729-42. PubMed ID: 21970655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.
    Varshosaz J; Hassanzadeh F; Sadeghi H; Khadem M
    J Liposome Res; 2012 Sep; 22(3):224-36. PubMed ID: 22385296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
    Gao Z; Li Z; Yan J; Wang P
    Drug Des Devel Ther; 2017; 11():2595-2604. PubMed ID: 28919710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.